This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brändlein, S. Articles by Vollmers, H. P. Search for Related Content PubMed PubMed Citation Articles by Brändlein, S. Articles by Vollmers, H. P.

Natural IgM Antibodies and Immunosurveillance Mechanisms against Epithelial Cancer Cells in Humans

Institute of Pathology, University of Würzburg, Würzburg, Germany

Malignancy is like a chronic disease, and the immune system is permanently involved in recognizing and eliminating the transformed cells. The human hybridoma technology offers the unique opportunity to study the mechanisms, structures, and targets involved in recognition and elimination of aberrant cells. Thousands of tumor-reactive human monoclonal antibodies were isolated by this technique from cancer patients and from healthy donors, and all of these antibodies were IgM antibodies; no IgG and IgA antibodies were found. Fourteen of these antibodies were selected for DNA sequence analysis, characterization of their binding patterns, and determination of their origin and genetics. All of the IgM antibodies studied expressed only few or no mutations at all (germ-line coded), bound to carbohydrates on modified tumor-specific receptors and induced apoptosis. The degree of cross-reactivity to other tumors correlated reciprocally with the number of mutations in coding regions. By using an anti-idiotypic antibody we were able to show that the IgM-producing cells were of CD5+ B-cell origin. The data presented here indicate that the innate immunity and natural IgM antibodies play an important role in immunosurveillance mechanisms against epithelial tumors in humans.

This article has been cited by other articles:

				P. Auguste, L. Fallavollita, N. Wang, J. Burnier, A. Bikfalvi, and P. Brodt The Host Inflammatory Response Promotes Liver Metastasis by Increasing Tumor Cell Arrest and Extravasation Am. J. Pathol., May 1, 2007; 170(5): 1781 - 1792. [Abstract] [Full Text] [PDF]

				S. Brandlein, N. Rauschert, L. Rasche, A. Dreykluft, F. Hensel, E. Conzelmann, H.-K. Muller-Hermelink, and H. P. Vollmers The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein Mol. Cancer Ther., January 1, 2007; 6(1): 326 - 333. [Abstract] [Full Text] [PDF]

				B. Monzavi-Karbassi, C. Artaud, F. Jousheghany, L. Hennings, J. Carcel-Trullols, S. Shaaf, S. Korourian, and T. Kieber-Emmons Reduction of Spontaneous Metastases through Induction of Carbohydrate Cross-Reactive Apoptotic Antibodies J. Immunol., June 1, 2005; 174(11): 7057 - 7065. [Abstract] [Full Text] [PDF]

				P. Carter, L. Smith, and M. Ryan Identification and validation of cell surface antigens for antibody targeting in oncology Endocr. Relat. Cancer, December 1, 2004; 11(4): 659 - 687. [Abstract] [Full Text] [PDF]

				T. Pohle, S. Brandlein, N. Ruoff, H. K. Muller-Hermelink, and H. P. Vollmers Lipoptosis: Tumor-Specific Cell Death by Antibody-Induced Intracellular Lipid Accumulation Cancer Res., June 1, 2004; 64(11): 3900 - 3906. [Abstract] [Full Text] [PDF]

				S. Varambally, Y. Bar-Dayan, J. Bayry, S. Lacroix-Desmazes, M. Horn, M. Sorel, Y. Bar-Dayan, G. Ruberti, M. D. Kazatchkine, and S. V. Kaveri Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells Int. Immunol., March 1, 2004; 16(3): 517 - 524. [Abstract] [Full Text] [PDF]